Search for: "Janssen Pharmaceutica, Inc." Results 21 - 40 of 57
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Oct 2021, 5:15 am by Dennis Crouch
Janssen Pharmaceutica, N.V., No. 21-202 (NHK-Fintiv rule for denying petitions; appealability of IPR petition denial); Apple Inc. v. [read post]
21 Nov 2008, 10:41 pm
My firm’s Partners, Jim Orr and Michael Heygood, were the lead attorneys representing the DiCosolo family in the case against the defendants, Janssen Pharmaceutica Inc. and ALZA Corporation. [read post]
23 Oct 2009, 4:12 pm
In In re ‘318 Patent Infringement Litigation (Janssen Pharmaceutica N.V. v. [read post]
13 Aug 2008, 5:00 am
Janssen Pharmaceutica, Inc., No. 07-12259, slip op. (11th Cir. [read post]
20 Sep 2021, 3:31 pm by Dennis Crouch
Janssen Pharmaceutica (appealing institution denials); Apple Inc. v. [read post]
17 Feb 2010, 5:10 am
(Patent Docs) Razadyne (Galantamine) / Strattera (Atomoxetine) – US: Walking the enablement/non-obviousness tightrope: Janssen Pharmaceutica N.V. v. [read post]
21 Jun 2018, 10:33 am by James Innocent
It was first developed by Janssen Pharmaceutica around 1960 and approved for American medical use in 1968 as an injectable anesthetic called Sublimaze. [read post]
2 Feb 2010, 7:28 am by Beck, et al.
N.J. 1981) (label change); Janssen Pharmaceutica, Inc. v. [read post]